Key facts
- Notable investors include CAS Star, Shaanxi Financial Asset Management, Shaaxi Shantou Capital, Shaanxi Growth Enterprise Guide Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Shaanxi Yungu Zhonghui Biopharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Shaanxi Yungu Zhonghui Biopharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shaanxi Yungu Zhonghui Biopharmaceutical
Operator of a biotechnology firm based in Xi'an, China. The company offers drug development and manufacturing capabilities, enabling healthcare providers to deliver effective treatments.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Shaanxi Yungu Zhonghui Biopharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shaanxi Yungu Zhonghui Biopharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shaanxi Yungu Zhonghui Biopharmaceutical in its N-PORT filings yet. We sweep new filings monthly.